2022-2023 EVENTS

2022 Events

28 Aug - 01 Sep 2022
The International Surgical Week (ISW)
Kuala Lumpur

31 Aug – 2 Sept 2022
Medical Fair Asia
Marina Bay Sands, Singapore

3-9 September
Medical Fair Asia
Digital, Online

9-10 September 2022
World Pediatrics Conference
Bangkok, Thailand

9-10 September 2022
World Heart and Cardiothoracic Surgery Conference
Bangkok, Thailand

19-21 September 2022
23rd SE-Asian Healthcare & Pharma Show
Kuala Lumpur

27-29 September 2022
Smart Healthcare Expo (Health Malaysia)

27-29 September 2022
Asia Pandemic Congress
Kuala Lumpur Convention Centre

19-20 September 2022
23nd Global Nursing Education Conference
Brisbane, Australia

30 Sep - 2 Oct 2022
Malaysia International Dental Show (MIDS)
Sunway Pyramid Convention Centre, Subang Jaya, Malaysia

7-9 November 2022
Saudi International MedLab Expo
Riyadh International Convention and Exhibition Center

7-9 November 2022
Saudi International Pharma Expo
Riyadh International Convention and Exhibition Center

11-13 November 2022
Eldercare Exhibition and Conference Asia (ELDEX Asia 2022)
Suntex Singapore Exhibition and Convention Centre

14-15 November 2022
Healthcare Asia Pacific
Osaka, Japan

2023 Events

30 May – 1 June 2023
KL Convention Centre, Kuala Lumpur

13-15 September 2023
Medical Fair Thailand
BITEC, Bangkok

Free counters!

The Health Ministry (MOH) said it has approved 359 transfer appeals by medical officers nationwide.

Health Minister Dr Zaliha Mustafa said the remaining bids will be processed according to vacancies.

“If an appeal has merit and there is a vacancy in the area they applied for, we will try to facilitate the request.

“But at the moment, we have to pause to make sure they do their job first, because their service as doctors and civil servants must continue,” she told reporters after launching the National Regulatory Conference 2023 organised by the National Pharmaceutical Regulatory Division (NPRA) and Malaysian Pharmacy Association here today.

Last month, Dr Zaliha said the ministry received 1,834 transfer appeals from medical officers, citing reasons such as the pursuit of specialist studies and serious family problems.

In her speech, Dr Zaliha said NPRA is looking into adopting an agile regulatory framework that can quickly adapt not only to scientific advancements and new pharmaceutical technologies, but also to emerging health threats.

She said this involves flexible approval pathways, expedited reviews for urgent medical needs, and an openness towards adaptive clinical trial designs.

“In response to resource limitations, NPRA is progressing from conventional and routine practices to a risk-based approach for both pre-market authorisation and post-market surveillance activities.

“It is high time for a structural or organisational reform to be considered for a more effective and efficient regulatory delivery system that will ultimately benefit public health and support the growth of a globally recognised pharmaceutical industry for the country,” she said.

Dr Zaliha said in 2019, the pharmaceutical industry market value and volume were reported at RM 9.18 billion and 309 million units, respectively, and that it is obvious the sector plays a critical role in the economic progress of the country and the growth of the healthcare system.

In ensuring the pharmaceutical industry can continue to make a significant and positive impact on local and global health outcomes, Dr Zaliha said she is confident today’s conference can offer an excellent opportunity for knowledge exchange and discussion on regulatory reforms.

The conference, themed Regulatory Agility: Navigating Winds of Change, was attended by 630 delegates from the government, academia, associations, and private sector. — Bernama